61
Participants
Start Date
May 31, 2010
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Placebo
Matching placebo in capsules administered as a single oral dose.
375 mg CK-2017357
375 mg CK-2017357 in capsules administered as a single oral dose.
500 mg CK-2017357
500 mg CK-2017357 in capsules administered as a single oral dose.
National Clinical Research - Richmond, Inc., Richmond
National Clinical Research - Norfolk, Inc., Norfolk
Jacksonville Center for Clinical Research, Jacksonville
Tampa Bay Medical Research, Clearwater
DMI Research, Inc, Pinellas Park
Henry Ford Hospital, Detroit
Baylor College of Medicine, Houston
Clinical Trials of Texas, Inc., San Antonio
Denver Health Medical Center, Denver
Tatum Ridge Internal Medicine, Phoenix
Apex Research Institute, Santa Ana
Stanford Hospital and Clinics, Stanford
Maine Research Associates, Auburn
University of Massachusetts Memorial Medical Center, Worcester
Lead Sponsor
Cytokinetics
INDUSTRY